These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 11254905)

  • 1. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
    Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
    Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA.
    Kano H; Hayashi T; Sumi D; Esaki T; Asai Y; Thakur NK; Jayachandran M; Iguchi A
    Biochem Biophys Res Commun; 1999 Jun; 259(2):414-9. PubMed ID: 10362523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of endothelium-dependent and Nomega-nitro-L-arginine methyl ester- and indomethacin-resistant arterial relaxation in high-cholesterol-diet fed rabbits by treatment with fluvastatin, an HMG-CoA reductase inhibitor.
    Mitani H; Kimura M
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):55-62. PubMed ID: 12827027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits.
    Pi J; Horiguchi S; Sun Y; Nikaido M; Shimojo N; Hayashi T; Yamauchi H; Itoh K; Yamamoto M; Sun G; Waalkes MP; Kumagai Y
    Free Radic Biol Med; 2003 Jul; 35(1):102-13. PubMed ID: 12826260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells.
    Ozaki K; Yamamoto T; Ishibashi T; Matsubara T; Nishio M; Aizawa Y
    Jpn J Pharmacol; 2001 Feb; 85(2):147-54. PubMed ID: 11286396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
    Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
    Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
    Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
    Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
    Nishimatsu H; Suzuki E; Satonaka H; Takeda R; Omata M; Fujita T; Nagai R; Kitamura T; Hirata Y
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1770-6. PubMed ID: 15550522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide.
    Thakur NK; Hayashi T; Sumi D; Kano H; Tsunekawa T; Iguchi A
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H75-83. PubMed ID: 11406471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
    Obata T; Ebihara A; Yamanaka Y
    Biochim Biophys Acta; 2001 Apr; 1536(1):55-63. PubMed ID: 11335104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
    Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits.
    Hayashi T; Rani P JA; Fukatsu A; Matsui-Hirai H; Osawa M; Miyazaki A; Tsunekawa T; Kano-Hayashi H; Iguchi A; Sumi D; Ignarro LJ
    Atherosclerosis; 2004 Oct; 176(2):255-63. PubMed ID: 15380447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
    Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
    Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA; Huang Q; Tesfamariam B
    Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.